Guangxi LiuYao Group Co., Ltd engages in the manufacturing, wholesale, and retail of pharmaceutical products in China. It offers various types of medicines, med...
Net inflow of CSPC PHARMA through Hong Kong Stock Connect is HKD 935 million
GUANGXI LIUYAO GROUP has repurchased a total of 9.7746 million shares at a cost of 180 million yuan
Zhitong A-share lock-up release overview | September 25
GUANGXI LIUYAO GROUP held a high-level exchange seminar with Huawei to explore cooperation in pharmaceutical intelligence
GUANGXI LIUYAO GROUP: The cumulative repurchased shares account for 2.04% of the total share capital
GUANGXI LIUYAO GROUP plans to repurchase shares worth 100 million to 200 million yuan